Getting Uncomfortable With Esketamine Carlat Reports

Getting Uncomfortable With Esketamine

The Carlat Psychiatry Blog, Volume , Number ,
https://www.thecarlatreport.com///

From The Carlat Psychiatry Blog, ,

Esketamine (Spravato) was approved in 2019 for treatment resistant depression, but the medicine quickly gathered controversy about its long-term safety. We interview Dr. Nolan Williams from Stanford University about these issues and where esketamine fits in our interventions for treatment resistant depression.

Date Published: 1/13/2020

Duration: 12 minutes, 21 seconds

Take the Podcast Survey to help us launch a CME option in 2020.

Suggested Articles

When Psilocybin was a Psych Med September 13, 2021 Phase III clinical trials are beginning to roll out for psychedelic medications like like psilocybin…
Treatment of Depression During Pregnancy July 19, 2022 Transcript of "Management of Depression in Pregnancy and the Postpartum" with Victoria Hendrick, MD. This…
The Best and Worst Antipsychotics for Mania - Part 2 October 25, 2021 In the final episode of our 3-part series on antipsychotics, you’re going to find out…
What Works Best in Treatment Resistant Depression Part 2 May 3, 2021 A new study looked at what works best after two antidepressants have failed, and it…

Powered by Contextual Related Posts

Getting Uncomfortable With Esketamine

Suggested Articles

Comments